Slone Partners Recruits CEO for Perspectum
October 7, 2026 – Life sciences-focused search firm Slone Partners has placed Warren Cresswell as CEO at Perspectum, an Oxford, England-based precision health company that delivers non-invasive solutions to accelerate drug development and improve patient outcomes in liver and cardiometabolic disease. “Warren brings an exceptional combination of global leadership experience, commercial expertise, and deep knowledge across diagnostics and precision health,” said Leslie Loveless, managing partner and CEO of Slone Partners. “His proven ability to build and scale organizations will be tremendously valuable as Perspectum advances its innovative technologies and expands its impact on drug development and patient care. We are delighted to have helped bring Warren and the Perspectum team together.”
“Warren’s breadth of experience made him an outstanding fit for Perspectum at this important stage of the company’s evolution,” said Sona Stroud, senior partner at Slone Partners, who led the search. “He brings a unique combination of scientific and technology expertise with the commercial and operational leadership needed to translate innovation into meaningful clinical and business impact. It was a genuine pleasure working with Perspectum’s highly accomplished and thoughtful board and with Warren, who is an exceptional leader and person. Bringing the two together made this search particularly rewarding, and I am incredibly excited to see what they accomplish.”
“I am thrilled with the selection by the board’s search committee of Warren Cresswell to serve as Perspectum’s next CEO,” said Michael Rosenblatt, chairperson, Perspectum. “Warren has the leadership talent and experience that are the right match for Perspectum at this time in its growth and development. We are most enthusiastic to have him at the helm.”
Mr. Cresswell is a global life sciences executive with more than 25 years of experience across diagnostics, pharmaceuticals, medical devices and laboratory services. He was previously president and CEO of Prometheus Laboratories, a Nestlé Health Science company, where he led the diagnostics business through a period of significant growth. He has built commercial and CLIA-certified laboratory infrastructure for FDA-cleared diagnostics in the United States, and most recently as CEO, he has led a precision oncology company.
“I am honored and excited to join Perspectum at such an important stage in the company’s evolution, and I am grateful to the board for the confidence they have placed in me,” said Mr. Cresswell. “Perspectum has built an exceptional scientific and technology platform that will meaningfully improve both drug development and patient care. I look forward to working with the talented team across the organization to build on that foundation, expand our global impact, and translate Perspectum’s innovation into meaningful value for patients, healthcare providers and shareholders.”
Related: Slone Partners Recruits Chief Business Officer for Vertero Therapeutics
Perspectum is a global medical technology company developing advanced imaging solutions that support earlier diagnosis and more personalized care for patients with cardiometabolic conditions. Operating across the U.K., EU, Asia, and the U.S., Perspectum combines biomedical science, clinical expertise and quantitative imaging analytics to help clinicians detect disease sooner and make more informed decisions about patient care.
Serving the Healthcare/Life Sciences Sector
Slone Partners is a nationally recognized senior-level recruitment provider that specializes in delivering executive, management, and leadership talent for the diagnostic, biopharmaceutical, healthcare information technology, and laboratory testing industries. The firm has offices in Boston, New York, Washington, D.C., and San Francisco. Recently, Slone Partners was included among Hunt Scanlon Media’s “Top 50 Healthcare & Life Sciences Search Firms.”
The Select Guide to America’s Top 250 Executive Search Firms
Hunt Scanlon Media proudly presents the Select Guide to America’s Top 250 Executive Search Firms.
This comprehensive online directory is your definitive resource for finding the best executive search firms to serve your talent needs.
Our guide is meticulously curated to connect you with leading firms that specialize in various industries and functions, ensuring you find the perfect match for your executive recruitment needs.
In 2000, Adam Slone founded Slone Partners and acted as CEO from 2000 to 2016. He remains chairman today. His industry knowledge and extensive contacts have enabled Slone Partners to place thousands of executives and industry professionals. Today, Mr. Slone remains engaged with Slone Partners, with a specific focus in strategy, finance, M&A advisement, and business development in Boston and California.
Ms. Loveless has nearly 20 years of healthcare industry and executive search experience to Slone Partners. She joined the firm in 2007, became COO in 2014 and CEO in 2016. At Slone Partners, Ms. Loveless acts as the leader of the organization as well as the head of the executive search team. Her involvement with clients and candidates enables her to understand the key motivations of each. As CEO, Ms. Loveless’ focus extends to cultivating new business partnerships and expanding relationships with existing clients. Through her leadership, life sciences and biotechnology have emerged as the primary client base for Slone Partners.
With more than 20 years of experience in healthcare and life sciences, Ms. Stroud has extensive market knowledge and a track record of key executive and leadership placements across multiple verticals and a wide array of companies. Before joining Slone Partners in 2011, she spent nearly a decade with Pfizer.
Related: Slone Partners Recruits Chief Business Officer for 1910 Genetics
Contributed by Scott A. Scanlon, Editor-in-Chief and Dale M. Zupsansky, Executive Editor – Hunt Scanlon Media
